Skip to search formSkip to main contentSkip to account menu

bimosiamose

Known as: 1,6-bis(3-(3-carboxymethylphenyl)-4-(2-alpha-D-mannopyranosyloxy)phenyl)hexane 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

HexanesMannose

Narrower (1)

TBC 1269
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Late-breaking abstract: Inhaled pan-selectin antagonist bimosiamose in COPD: A double-blind, randomized, placebo-controlled phase II study
Background: Bimosiamose a pan-selectin antagonist, previously attenuated ozone-induced airway-inflammation in healthy volunteers… 
Review
2008
Review
2008
Recent Developments in Targeting Eosinophil Accumulation as a Novel Therapeutic Approach for Asthma
Current therapies for asthma are aimed at controlling disease symptoms and for the majority of patients inhaled glucocorticoid… 
2007
2007
The pharmacokinetics of subcutaneously injected bimosiamose disodium in healthy male volunteers
Bimosiamose is a novel synthetic pan‐selectin antagonist developed for the treatment of acute and chronic inflammatory disorders… 
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials reported in current literature and congresses. The data… 
2003
2003
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)